You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 23, June 16, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Colon Cancer
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

C-Reactive Protein and Risk of Colon Cancer

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Erlinger and colleagues1 reported that C-reactive protein (CRP) levels were associated with risk of colon cancer. We have suggested that CRP is not merely a nonspecific marker of inflammation but has several important proinflammatory effects.2-3 In particular, CRP may activate endothelial cells, monocytes and smooth muscle cells, induce expression of adhesion molecules,2 chemoactractants,3 tissue factor, and activate the NF-{kappa}B pathway.4 Although we are not aware of any studies on the effect of CRP on cancer cells or on epithelial cells of the gastrointestinal tract, expression of adhesion molecules is important for cancer invasion and activation of the NF-{kappa}B pathway may have important oncogenic effects.5

Thus, it is possible that direct effects of CRP may contribute to its association with colon cancer. Statins, used as cholesterol-lowering drugs, may also reduce CRP and it would be interesting to know whether these drugs can reduce the incidence . . . [Full Text of this Article]

Vincenzo Pasceri, MD, PhD
vpasceri@hotmail.com
Department of Cardiovascular Science
San Filippo Neri Hospital

Giovanni Cammarota, MD
Department of Gastroenterology
Catholic University
Rome, Italy



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

C-Reactive Protein and Risk of Colon Cancer
Moutasim H. Al-Shaer
JAMA. 2004;291(23):2819.
EXTRACT | FULL TEXT  

C-Reactive Protein and Risk of Colon Cancer—Reply
Thomas P. Erlinger, Elizabeth Platz, Kathy J. Helzlsouer, and Nader Rifai
JAMA. 2004;291(23):2819.
EXTRACT | FULL TEXT  

C-Reactive Protein and the Risk of Incident Colorectal Cancer
Thomas P. Erlinger, Elizabeth A. Platz, Nader Rifai, and Kathy J. Helzlsouer
JAMA. 2004;291(5):585-590.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.